| Authors | Efstathios Kastritis, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Maria Roussou, Evdoxia Hadjiharissi, Argyris Symeonidis, Panagiotis Repoussis, Evridiki Michalis, Sosana Delimpasi, Konstantinos Tsatalas, Panagiotis Tsirigotis, Amalia Vassou, Elina Vervessou, Eirini Katodritou, Dimitra Gika, Evangelos Terpos, Meletios A Dimopoulos |
| Journal | Blood
(Blood)
Vol. 126
Issue 11
Pg. 1392-4
(Sep 10 2015)
ISSN: 1528-0020 [Electronic] United States |
| PMID | 26359434
(Publication Type: Clinical Trial, Phase II, Letter, Multicenter Study, Randomized Controlled Trial)
|
| Chemical References |
- Rituximab
- Dexamethasone
- Cyclophosphamide
|
| Topics |
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Cyclophosphamide
(administration & dosage)
- Dexamethasone
(administration & dosage)
- Disease Progression
- Disease-Free Survival
- Humans
- Middle Aged
- Rituximab
(administration & dosage)
- Treatment Outcome
- Waldenstrom Macroglobulinemia
(drug therapy)
|
